2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the US Food and Drug Administration (FDA). The FDA established the Standardized Data Collection for Cardiovascular Trials Initi...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) Vol. 137; no. 9; p. 961
Main Authors: Hicks, Karen A, Mahaffey, Kenneth W, Mehran, Roxana, Nissen, Steven E, Wiviott, Stephen D, Dunn, Billy, Solomon, Scott D, Marler, John R, Teerlink, John R, Farb, Andrew, Morrow, David A, Targum, Shari L, Sila, Cathy A, Hai, Mary T Thanh, Jaff, Michael R, Joffe, Hylton V, Cutlip, Donald E, Desai, Akshay S, Lewis, Eldrin F, Gibson, C Michael, Landray, Martin J, Lincoff, A Michael, White, Christopher J, Brooks, Steven S, Rosenfield, Kenneth, Domanski, Michael J, Lansky, Alexandra J, McMurray, John J V, Tcheng, James E, Steinhubl, Steven R, Burton, Paul, Mauri, Laura, O'Connor, Christopher M, Pfeffer, Marc A, Hung, H M James, Stockbridge, Norman L, Chaitman, Bernard R, Temple, Robert J
Format: Journal Article
Language:English
Published: United States 27.02.2018
Subjects:
endpoints
cardiovascular outcomes
clinical trial endpoints
stroke outcomes
endpoint definitions
cardiovascular and stroke outcome definitions
outcome definitions
cardiovascular endpoints
stroke endpoint definitions
cardiovascular and stroke endpoint definitions
clinical trial endpoint definitions
cardiovascular endpoint definitions
cardiovascular and stroke outcomes
stroke endpoints
ISSN:1524-4539, 1524-4539
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the US Food and Drug Administration (FDA). The FDA established the Standardized Data Collection for Cardiovascular Trials Initiative in 2009 to simplify the design and conduct of clinical trials intended to support marketing applications. The writing committee recognizes that these definitions may be used in other types of clinical trials and clinical care processes where appropriate. Use of these definitions at the FDA has enhanced the ability to aggregate data within and across medical product development programs, conduct meta-analyses to evaluate cardiovascular safety, integrate data from multiple trials, and compare effectiveness of drugs and devices. Further study is needed to determine whether prospective data collection using these common definitions improves the design, conduct, and interpretability of the results of clinical trials.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1524-4539
1524-4539
DOI:10.1161/CIRCULATIONAHA.117.033502